Jazz reports Phase III trial interim results for Ziihera combination

Jazz Pharmaceuticals has reported second interim analysis results of the Phase III HERIZON-GEA-01 trial evaluating Ziihera plus chemotherapy in adults receiving first-line treatment for HER2-positive cancer.

The post Jazz reports Phase III trial interim results for Ziihera combination appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.